Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations | Scientific Reports
BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications | Oncotarget
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA | Nature Medicine
Frontiers | Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM
Veterinary Sciences | Free Full-Text | Comparative Aspects of BRAF Mutations in Canine Cancers
Význam testování RAS u kolorektálního karcinomu
Cancers | Free Full-Text | Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
BRAF (gene) - Wikipedia
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Leukemia
Frontiers | Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy - Decaussin‐Petrucci - 2017 - Cytopathology - Wiley Online Library
IJMS | Free Full-Text | The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
Frontiers | BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy - Decaussin‐Petrucci - 2017 - Cytopathology - Wiley Online Library
BRAF Mutation in Colorectal Cancer Anita Turk, MD; Dustin Deming, MDDivision of Hematology and Oncology,Department of MedicineUniversity of Wisconsin-Madison School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center,
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF: Cell
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
BRAF gene: From human cancers to developmental syndromes - ScienceDirect
Genes | Free Full-Text | Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories - ScienceDirect
Mutant KRAS can induce either BRAF/BRAF or BRAF-CRAF dimerazaiton of... | Download Scientific Diagram
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling | Science Signaling
Frontiers | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? - ecancer
